Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Trending Stock Alerts

BSX Stock - Boston Scientific Corporation Stock Trading


home / stock / bsx

BSX BSX Quote BSX Short BSX News BSX Articles BSX Message Board

MWN AI Summary *

Boston Scientific Corporation (NYSE: BSX) is a leading global medical device manufacturer focused on developing innovative solutions to improve the health of patients worldwide. Founded in 1979 and headquartered in Marlborough, Massachusetts, the company specializes in a wide range of medical devices that address various medical conditions across multiple therapeutic areas, including cardiology, urology, endoscopy, and pain management.

Boston Scientific is recognized for its commitment to advancing medical technology and enhancing patient care. The company has a diverse product portfolio, which includes minimally invasive and non-invasive therapeutic solutions, catering to both patients and healthcare providers. Some of its well-known products include drug-eluting stents, cardiac rhythm management devices, and bladder control solutions.

In recent years, Boston Scientific has focused on expanding its presence in high-growth markets, including emerging economies, where increasing demand for healthcare solutions presents significant opportunities. The company has engaged in strategic acquisitions to enhance its product offerings and expand its market reach. Notable acquisitions include the takeover of BTG plc, which has strengthened its interventional oncology and vascular medicine capabilities.

Boston Scientific's commitment to innovation is reflected in its substantial investment in research and development, which enables the company to introduce cutting-edge products and treatments. The company's pipeline of new products positions it well to continue driving growth and shareholder value over the long term.

The stock performance of Boston Scientific has shown resilience, with steady growth driven by robust demand for its medical devices and strategic positioning within the healthcare sector. As of October 2023, Boston Scientific continues to be an attractive investment choice for those looking to capitalize on the growing medical device market, particularly as the global population ages and the demand for medical interventions increases.

MWN AI Analysis *

Boston Scientific Corporation (NYSE: BSX) operates in the highly competitive medical device industry, focusing on innovative solutions for a range of medical conditions, including cardiovascular, rhythm management, and endoscopy. As of October 2023, BSX has demonstrated robust growth potential, driven by a combination of strong product demand, strategic acquisitions, and continuous investment in research and development.

Analyzing Boston Scientific's recent financial performance reveals a promising upward trajectory in revenue, bolstered by the ongoing recovery in elective procedures post-pandemic. The company reported a year-over-year revenue increase of approximately 10% in its latest quarterly earnings, largely attributed to strong sales in the cardiovascular and electrophysiology segments. This upward trend is expected to continue as healthcare systems further normalize and embrace advanced medical technologies.

From a valuation perspective, BSX's price-to-earnings (P/E) ratio, while currently above the industry average, reflects the market's confidence in its future growth. Additionally, its commitment to innovation, including the launch of potentially groundbreaking technologies and devices, should provide a sustained competitive edge.

Despite the positive outlook, investors should remain cautious of potential risks. Regulatory hurdles, increasing competition, and market volatility could impact performance. Moreover, supply chain challenges have been a persistent issue across the sector, and investors should monitor how effectively Boston Scientific navigates these dynamics.

In conclusion, Boston Scientific Corporation presents a compelling investment opportunity, underpinned by its solid financial growth, innovative product pipeline, and leading market position. Long-term investors seeking exposure in the healthcare sector may find BSX an attractive proposition, while short-term investors should keep a close watch on market conditions and regulatory developments. Overall, maintaining a balanced approach with a focus on the company's growth trajectory may yield favorable results in the coming quarters.

* MWN AI Summary and Analysis is based on asking OpenAI to summarize and analyze the company and stock symbol.


About | Boston Scientific Corporation (NYSE:BSX)

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Quote | Boston Scientific Corporation (NYSE:BSX)

Last:$106.04
Change Percent: -0.55%
Open:$105.44
Close:$106.04
High:$106.24
Low:$104.72
Volume:7,258,671
Last Trade Date Time:05/16/2025 03:41:42 pm

News | Boston Scientific Corporation (NYSE:BSX)

  • Short bets against S&P 500 healthcare stocks climb in April; MRNA retains top shorted ranking

    2025-05-15 09:35:30 ET The average short interest for the S&P 500 Health Care Index Sector ( NYSEARCA: XLV ) experienced an increase in April, moving from 1.81% in March to 1.95%, indicating a collective rise in negative bets against the broader healthcare industry. Notably, Mod...

    • May 15, 2025 09:35:30 am

    • |
    • SeekingAlpha
    • |
      • BSX Stock
      • BSX Quote
      • BSX Short
      • BSX News
      • BSX Articles
      • BSX Message Board
  • BlackRock Health Sciences Opportunities Fund Q1 2025 Commentary

    2025-05-14 15:38:00 ET Summary BlackRock Health Sciences Opportunities Fund posted returns of 3.66% (Institutional shares) and 3.60% (Investor A shares, without sales charge) for the first quarter of 2025. During the quarter, the fund increased its exposure to the health care prov...

    • May 14, 2025 03:38:00 pm

    • |
    • SeekingAlpha
    • |
      • BSX Stock
      • BSX Quote
      • BSX Short
      • BSX News
      • BSX Articles
      • BSX Message Board

Message Board Posts | Boston Scientific Corporation (NYSE:BSX)

Subject By Source When
whytestocks: $BSX News Article - Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High whytestocks investorshangout 04/05/2023 4:30:47 PM
whytestocks: $BSX News Article - Boston Scientific ($BSX) Trading Report whytestocks investorshangout 04/04/2023 4:50:48 PM
whytestocks: $BSX News Article - Boston Scientific: One of Glassdoor's Best Places to Work in 2022 whytestocks investorshangout 02/03/2022 8:55:48 PM
whytestocks: $BSX News Article - Boston Scientific Corp (BSX) Q2 2021 Earnings Call Transcript whytestocks investorshangout 07/27/2021 8:40:48 PM
whytestocks: $BSX News Article - Boston Scientific Receives FDA Approval For The Vercise Genus(TM) D whytestocks investorshangout 01/22/2021 1:35:50 PM

MWN AI FAQ **

How does Boston Scientific Corporation BSX plan to navigate the competitive landscape in the medical device industry over the next few years, particularly in terms of innovation and market share?

Boston Scientific Corporation plans to navigate the competitive landscape by focusing on continuous innovation in its product offerings, expanding its portfolio through strategic acquisitions, and enhancing its market presence in key therapeutic areas to increase market share.

What are the key growth drivers for Boston Scientific Corporation BSX, and how can investors expect these to impact financial performance in upcoming quarters?

Key growth drivers for Boston Scientific Corporation include innovative product launches in cardiology and rhythm management, expansion in emerging markets, and increasing procedural volumes, which investors can expect to positively influence financial performance in the upcoming quarters.

Can you provide insights into Boston Scientific Corporation BSX's recent product launches and how they align with current trends in healthcare technology and patient needs?

Boston Scientific's recent product launches, focusing on minimally invasive procedures and advanced digital health solutions, align with trends toward enhanced patient outcomes and cost efficiency in healthcare technology, addressing growing patient needs for less invasive treatment options.

How is Boston Scientific Corporation BSX managing its supply chain challenges, and what strategies are in place to ensure consistent product availability for its growing customer base?

Boston Scientific Corporation (BSX) is addressing supply chain challenges by diversifying suppliers, investing in digital technology for better demand forecasting, and implementing strategic inventory management practices to ensure consistent product availability for its expanding customer base.

** MWN AI Questions are based on asking OpenAI to ask and answer four questions about the company and stock symbol.

Stock Information

Get BSX Alerts

News, Short Squeeze, Breakout and More Instantly...

Boston Scientific Corporation Company Name:

BSX Stock Symbol:

NYSE Market:

-0.55% G/L:

$106.04 Last:

7,258,671 Volume:

$105.44 Open:

$106.04 Close:

Boston Scientific Corporation Website:

Boston Scientific Corporation Logo

Ad

Trending Stock Alerts
RECENT BSX NEWS
  • BSX - Boston Scientific announces upcoming investor conference schedule

    Boston Scientific announces upcoming investor conference schedule PR Newswire MARLBOROUGH, Mass. , May 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May. On May 13, 202...

  • BSX - BSX Price Target Alert: $117.00. Issued by Truist Financial

    2025-04-24 12:13:55 ET Richard Newitter from Truist Financial issued a price target of $117.00 for BSX on 2025-04-24 13:47:24. The adjusted price target was set to $117.00. At the time of the announcement, BSX was trading at $100.55. The overall price target consensus is...

  • BSX - Boston Scientific Corporation (BSX) Q1 2025 Earnings Beat Expectations

    2025-04-23 20:03:39 ET Key Points ... Full story available on KlickAnalytics.com

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your X Account

Link your X Account to Market Wire News

When you linking your X Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

Be alerted of any news about your stocks and see what other stocks are trending.



Trending Stock Alerts

Trending Stock Alerts

Our Next Stock Alert could be Coming in Minutes!

Sign Up Today To Get Full Access To Our Next Stock Report!

  • Day Before Email and Text Notifications of New Alerts
  • Day of Email and Text Notifications
  • Trending Stocks, Watchlist and News Releases
  • Mobile App Notifications

Trending Stock Alerts

Get BSX Alerts

Get BSX Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.


Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2025 Market Wire News 1